Merck logo

Associate Scientist, Post Doc Fellow- Computational Pathology & Spatial AI

Merck

Cambridge, MAHybridPosted 41 days ago$82,000 - $92,000
Full TimeNew Grad & Entry LevelBioinformatics & Data SciencePharmaceuticalH1B sponsorship
Original posting ↗

Summary

Within DAGS, our AI/ML team develops biologically grounded and interpretable machine learning methods to accelerate biomarker discovery across oncology. We are seeking a highly motivated Postdoctoral Research Fellow to develop next-generation multimodal AI approaches that integrate histopathology, transcriptomics, and spatial biology to characterize tumor microenvironment architecture and generate novel biological insights from routine H&E pathology images.

Job description

What You'll Do

  • Advance AI/ML methods that connect pathology images with molecular and spatial biology data.
  • Develop interpretable computational approaches to study tissue organization, tumor microenvironment biology, and disease-relevant patterns.
  • Integrate multimodal datasets to support biomarker discovery and biological hypothesis generation.
  • Collaborate with multidisciplinary teams across data science, pathology, biology, and translational research.
  • Communicate scientific findings through presentations, publications, and cross-functional discussions.

Education Requirement

Must currently hold a PhD OR receive a Ph.D. no later than spring 2027 in Computer Science, AI/ML, Computational Biology, Bioinformatics, Biomedical Engineering, Statistics, Applied Mathematics, or a related quantitative discipline.

Required Skills and Experience

  • Computational Pathology, Deep Learning, Computer Vision, Multimodal AI, Transcriptomics, Foundation Models, Oncology, Tumor Microenvironment, Spatial Biology.
  • Strong expertise in machine learning, deep learning, and data science.
  • Proficiency in Python and deep learning frameworks such as PyTorch.
  • Experience with computer vision, representation learning, multimodal modeling, or biomedical data analysis.
  • Demonstrated research productivity through publications, preprints, or conference presentations.
  • Ability to communicate complex technical concepts to multidisciplinary scientific teams.

Preferred Skills and Experience

  • Computational pathology.
  • Spatial transcriptomics, RNA-seq, or single-cell omics analysis.
  • Foundation models, transformers, and multimodal learning.
  • Tumor microenvironment biology and oncology biomarker discovery.
  • Publications in venues such as MICCAI, CVPR, NeurIPS, ISMB, AACR, or related journals.

Requirements

  • Must currently hold a PhD or receive a PhD no later than spring 2027
  • PhD in Computer Science, AI/ML, Computational Biology, Bioinformatics, Biomedical Engineering, Statistics, Applied Mathematics, or related quantitative discipline
  • Strong expertise in machine learning, deep learning, and data science
  • Proficiency in Python and deep learning frameworks such as PyTorch
  • Experience with computer vision, representation learning, multimodal modeling, or biomedical data analysis
  • Demonstrated research productivity through publications, preprints, or conference presentations
  • Ability to communicate complex technical concepts to multidisciplinary scientific teams

Benefits

  • Medical, Dental & Vision
  • Retirement Benefits
  • 401(k)
  • Paid Holidays
  • Vacation
  • Compassionate & Sick Days
  • Annual Bonus
  • Long-Term Incentive

Company overview

Merck & Co., Inc., known as Merck in the United States and Canada and MSD (Merck Sharp & Dohme) internationally, is a premier American multinational pharmaceutical company headquartered in Rahway, New Jersey. Founded in 1891 as the U.S. subsidiary of the German Merck Group, the company became independent following World War I and has since grown into one of the world's largest biomedical companies, ranking fourth globally by revenue. Merck operates across three core business segments: pharmaceuticals, vaccines, and animal health products. The company is renowned for its groundbreaking research and development, having brought numerous life-saving medicines to market including Keytruda (pembrolizumab), a leading immunotherapy for cancer treatment that generated $29.5 billion in 2024 revenue, and Gardasil, a revolutionary HPV vaccine. With approximately 75,000 employees worldwide, Merck maintains a robust pipeline of innovative therapies focused on oncology, vaccines, hospital acute care, cardiology, neuroscience, virology, immunology, and diabetes. The company invests heavily in R&D, spending $17.9 billion in 2024 alone, demonstrating its commitment to advancing scientific discovery. Merck's legacy spans over 130 years of bringing hope to humanity through important medicines and vaccines, operating with a purpose to use leading-edge science to save and improve lives globally while fostering an inclusive workforce and responsible business practices.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.